Diagnostic Imaging

OCTOBER 11, 2023

In a study of over 25,000 Medicare beneficiaries with mild cognitive decline or dementia, researchers found that obtaining amyloid positron emission tomography (PET) scans resulted in no statistically significant differences upon subsequent hospitalization and emergency department visit rates at one year.

PET Scan 78

PET Scan Hospital Medicare 78

Diagnostic Imaging

NOVEMBER 13, 2023

Experts highlight gallium-based and PyL PSMA-PET scans for use in prostate cancer, commenting on approvals as well as how the agents are made.

PET Scan 52

PET Scan 52

Diagnostic Imaging

NOVEMBER 13, 2023

Radiology experts discuss the current knowledge and use of PSMA-PET screening among colleagues, as well as unmet needs.

PET Scan 81

PET Scan Radiology 81

AuntMinnie

MARCH 26, 2024

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

TRA Medical Imaging

NOVEMBER 29, 2024

In addition to PSMA PET, we offer theranostic treatment options for patients with PSMA-positive prostate cancer, combining targeted therapy with diagnostic imaging for a personalized approach to treatment. Fast, Local, and Convenient Care We understand the importance of timely results for your peace of mind.

Imaging 59

Imaging Medical Imaging PET Scan Disease 59

Diagnostic Imaging

JANUARY 25, 2024

For patients with recurrent prostate cancer, PET scanning with 18F-flotufolastat led to major changes in treatment for 80 percent of patients and 75 percent of patients with a changed treatment focus to watchful waiting had negative scans, according to new research presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers (..)

PET Scan 90

PET Scan Imaging Clinic 90

Diagnostic Imaging

MAY 30, 2023

Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum (..)

PET Scan 84

PET Scan Imaging 84

Diagnostic Imaging

JULY 19, 2023

Recognizing the advent of beta amyloid-targeted therapies for the treatment of Alzheimer’s disease, the Centers for Medicare and Medicaid (CMS) has proposed eliminating coverage restrictions that limit amyloid positron emission tomography (PET) scans to clinical trial participants and one amyloid PET scan per lifetime.

Disease 52

Disease PET Scan Medicare Imaging 52

AuntMinnie

JUNE 20, 2024

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 130

Imaging Technology

MAY 30, 2023

It represents a new class of purposely engineered, high-affinity PSMA-targeted radiopharmaceuticals based on novel radiohybrid technology, which may offer diagnostic imaging and therapeutic potential. Results demonstrated high detection rates (% positive PET scans) even at low PSA levels.

Diagnostic 97

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 97

Open Medscience

AUGUST 18, 2024

Diagnostic imaging in motor neurone disease (MND) is crucial for early detection, disease monitoring, and differentiating from other conditions. The post Motor Neurone Disease: Diagnosis and Future Research Insights appeared first on Open MedScience.

Disease 52

Disease Diagnostic Imaging Diagnostic Imaging 52

Associates in Medical Imaging

FEBRUARY 15, 2021

MRI technologies are also particularly beneficial for scanning the brain, spine, soft tissues in the joints, and the interior structures of bones. However, this is also the case with virtually any other form of diagnostic imaging.

Magnetic Resonance Imaging 52

Magnetic Resonance Imaging Imaging Modalities Diagnostic MRI 52

TRA Medical Imaging

NOVEMBER 29, 2024

In addition to PSMA PET, we offer theranostic treatment options for patients with PSMA-positive prostate cancer, combining targeted therapy with diagnostic imaging for a personalized approach to treatment. Fast, Local, and Convenient Care We understand the importance of timely results for your peace of mind.

Imaging 52

Imaging Medical Imaging PET Scan Disease 52

Imaging Technology

MAY 2, 2023

For example, results showed that among the subgroup (n=76) of patients in the Evaluable PET Scan Population who had undergone primary treatment with radiation therapy for prostate cancer, the overall patient-level DR was 99% (75/76) and consistently high across the three independent readers (range 93-99%).

Diagnostic 98

Diagnostic Radiopharmaceuticals Imaging Radiation 98

Independent Imaging

APRIL 24, 2020

Diagnostic imaging plays a very important role in modern medicine. A CT (computerized tomography) scan is used to enable doctors to see clear images of the structures and tissues of your body. This type of scan may be ordered for a number of reasons, from detecting a joint problem to assessing a tumor for changes.

X-ray 52

X-ray Diagnostic Imaging Radiologist Imaging 52

TRA Medical Imaging

APRIL 17, 2025

If you or a loved one has been experiencing memory loss, confusion, or cognitive changes, your doctor may recommend an Amyloid PET/CT scan. This advanced imaging study, now offered at TRA Medical Imaging , is designed to help doctors evaluate changes in the brain that may be linked to Alzheimers disease and other types of dementia.

Diagnose 52

Diagnose Medical Imaging Disease Medical 52